Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M65,304Revenue (TTM) $M20,556Net Margin (%)11.1Altman Z-Score3.8
Enterprise Value $M70,057EPS (TTM) $1.5Operating Margin %14.0Piotroski F-Score5
P/E(ttm)29.4Beneish M-Score-2.4Pre-tax Margin (%)11.0Higher ROA y-yN
Price/Book3.210-y EBITDA Growth Rate %-5.0Quick Ratio1.2Cash flow > EarningsY
Price/Sales3.25-y EBITDA Growth Rate %-7.7Current Ratio1.5Lower Leverage y-yN
Price/Free Cash Flow38.3y-y EBITDA Growth Rate %-6.5ROA % (ttm)5.4Higher Current Ratio y-yN
Dividend Yield %2.3PEG--ROE % (ttm)10.6Less Shares Outstanding y-yY
Payout Ratio %70.0Shares Outstanding M1,469ROIC % (ttm)72.8Gross Margin Increase y-yY

Gurus Latest Trades with ABT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ABTJoel Greenblatt 2016-03-31 Add0.35%$36.34 - $44.91
($39.68)
$ 44.4512%Add 771.99%861,862
ABTGeorge Soros 2016-03-31 Reduce-0.2%$36.34 - $44.91
($39.68)
$ 44.4512%Reduce -36.89%419,181
ABTRobert Olstein 2016-03-31 Add0.11%$36.34 - $44.91
($39.68)
$ 44.4512%Add 9.45%220,000
ABTFirst Eagle Investment 2016-03-31 Add0.09%$36.34 - $44.91
($39.68)
$ 44.4512%Add 12.53%7,507,515
ABTRichard Pzena 2016-03-31 Reduce-0.06%$36.34 - $44.91
($39.68)
$ 44.4512%Reduce -4.50%4,642,170
ABTKen Fisher 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 44.4512%Reduce -10.84%15,413
ABTMario Gabelli 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 44.4512%Reduce -22.30%13,695
ABTDodge & Cox 2016-03-31 Reduce$36.34 - $44.91
($39.68)
$ 44.4512%Reduce -3.30%29,268
ABTJoel Greenblatt 2015-12-31 Reduce-0.53%$39.89 - $46.05
($44.24)
$ 44.450%Reduce -93.21%98,838
ABTRobert Olstein 2015-12-31 Add0.15%$39.89 - $46.05
($44.24)
$ 44.450%Add 14.20%201,000
ABTRichard Pzena 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 44.450%Reduce -6.31%4,861,129
ABTVanguard Health Care Fund 2015-12-31 Reduce-0.08%$39.89 - $46.05
($44.24)
$ 44.450%Reduce -13.14%6,027,260
ABTGeorge Soros 2015-12-31 Reduce-0.05%$39.89 - $46.05
($44.24)
$ 44.450%Reduce -9.20%664,181
ABTFirst Eagle Investment 2015-12-31 Reduce-0.02%$39.89 - $46.05
($44.24)
$ 44.450%Reduce -2.26%6,671,344
ABTKen Fisher 2015-12-31 Add$39.89 - $46.05
($44.21)
$ 44.451%Add 13.32%17,286
ABTRichard Pzena 2015-09-30 Reduce-0.32%$39.06 - $51.2
($47.14)
$ 44.45-6%Reduce -18.17%5,188,346
ABTJoel Greenblatt 2015-09-30 Add0.16%$39.06 - $51.2
($47.14)
$ 44.45-6%Add 39.49%1,455,289
ABTRobert Olstein 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 44.45-6%Add 10.69%176,000
ABTFirst Eagle Investment 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 44.45-6%Add 15.36%6,825,289
ABTGeorge Soros 2015-09-30 Add0.09%$39.06 - $51.2
($47.14)
$ 44.45-6%Add 21.47%731,481
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ABT is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ABT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Warmuth Michael JExecutive Vice President 2016-07-26Sell26,800$43.492.16view
Funck Robert EVice President, Controller 2016-07-25Sell26,800$43.083.13view
WHITE MILES DChairman and CEO 2016-07-25Buy17,933$43.342.51view
WHITE MILES DChairman and CEO 2016-07-25Buy176,804$43.262.7view
WHITE MILES DChairman and CEO 2016-07-25Buy112,953$43.342.51view
WHITE MILES DChairman and CEO 2016-07-25Buy181,263$43.192.87view
WHITE MILES DChairman and CEO 2016-07-25Buy242,547$43.182.89view
ALLEN HUBERT LExecutive Vice President 2016-06-28Sell3,400$37.1419.63view
Watkin JaredSenior Vice President 2016-06-15Sell552$37.6318.07view
YOOR BRIAN BSenior Vice President and CFO 2016-06-01Sell565$39.4912.51view

Quarterly/Annual Reports about ABT:

News about ABT:

Articles On GuruFocus.com
Becton Dickinson: 19% EPS Growth With Good Dividends Jun 26 2016 
Opinions Differ on Abbott Deal to Acquire St. Jude's Medical Jun 18 2016 
This Health Care Dividend Aristocrat Will Profit From Old Age – Globally May 29 2016 
Ackman Selling Zoetis, But Other Firms Are Jumping In May 10 2016 
Bearish Sentiment in Becton Dickinson's Stock Apr 27 2016 
Stocks Murray Stahl Bought for Past 2 Quarters Apr 26 2016 
A Cheap Dividend Aristocrat Yielding Over 4% Mar 02 2016 
Valeant's Share Price Continues to Decline Feb 05 2016 
Abbott a Dividend Aristocrat Stock Propelled by Emerging Markets Dec 11 2015 
Baxalta Vs. AbbVie: Biopharma Spin-Off Battle Aug 20 2015 

More From Other Websites
Oracle buying Netsuite for $9.3 billion cash Jul 28 2016
​Alere loses $1B of value in 20 minutes after reports of new federal subpoena Jul 28 2016
Faber Report: Alere shares soar Jul 28 2016
Alere Faces Criminal Probe Over Medicare, Medicaid Billing Jul 27 2016
Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $7.6 million of Stocks Jul 27 2016
Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $7.8 million of Stocks Jul 27 2016
Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $4.9 million of Stocks Jul 27 2016
Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $777,216 of Stocks Jul 27 2016
Abbott Laboratories (ABT) Chairman and CEO Miles D White Bought $10.5 million of Stocks Jul 27 2016
Diagnostic tester Alere plunges on reports of second front in criminal probe Jul 27 2016
Alere shares plummet after feds launch criminal probe into billing Jul 27 2016
Abbott CEO Spends $45.5 Million to Boost Personal Stock Holdings Jul 27 2016
Alere faces criminal probe over Medicare, Medicaid Billing - WSJ Jul 27 2016
Alere (ALR) Stock Plunged on Criminal Probe, CNBC's DeAngelis Says Jul 27 2016
Alere Plunges by Record on Report of U.S. Criminal Probe Jul 27 2016
Top 10 Dividend Aristocrats to Buy at a Discount Now Jul 27 2016
Massachusetts class-action lawsuit filed over Alere's blood test Jul 25 2016
Abbott Laboratories Avoids a ‘Sell’ Rating from Analysts Jul 25 2016
The Economy, Interest Rates, Earnings and the Markets Jul 25 2016
New Research Reports on NFLX, AXP, GM & Others Jul 22 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)